PL411023A1 - Igła do biopsji stercza - Google Patents

Igła do biopsji stercza

Info

Publication number
PL411023A1
PL411023A1 PL411023A PL41102315A PL411023A1 PL 411023 A1 PL411023 A1 PL 411023A1 PL 411023 A PL411023 A PL 411023A PL 41102315 A PL41102315 A PL 41102315A PL 411023 A1 PL411023 A1 PL 411023A1
Authority
PL
Poland
Prior art keywords
cannula
prostate biopsy
active agent
biologically active
needle
Prior art date
Application number
PL411023A
Other languages
English (en)
Other versions
PL232535B1 (pl
Inventor
Marcin Sieczkowski
Artur Gibas
Marcin Matuszewski
Original Assignee
Marcin Sieczkowski
Artur Gibas
Marcin Matuszewski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marcin Sieczkowski, Artur Gibas, Marcin Matuszewski filed Critical Marcin Sieczkowski
Priority to PL411023A priority Critical patent/PL232535B1/pl
Priority to CA2989103A priority patent/CA2989103C/en
Priority to BR112017015160-0A priority patent/BR112017015160B1/pt
Priority to ES16704946T priority patent/ES2820377T3/es
Priority to EP16704946.9A priority patent/EP3247282B1/en
Priority to PCT/PL2016/000006 priority patent/WO2016118026A2/en
Priority to US15/545,279 priority patent/US10660622B2/en
Priority to JP2017557265A priority patent/JP6716606B2/ja
Priority to AU2016209742A priority patent/AU2016209742B2/en
Publication of PL411023A1 publication Critical patent/PL411023A1/pl
Publication of PL232535B1 publication Critical patent/PL232535B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A61B10/0241—Pointed or sharp biopsy instruments for prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A61B10/0266—Pointed or sharp biopsy instruments means for severing sample
    • A61B10/0275—Pointed or sharp biopsy instruments means for severing sample with sample notch, e.g. on the side of inner stylet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Igła do biopsji stercza składająca się z kaniuli (1) i osadzonego przesuwnie w kaniuli (1) ostro zakończonego mandrynu (2), oraz w tylnej części z uchwytów (3a, 3b) do pistoletu biopsyjnego, charakteryzuje się tym, że wewnętrzna powierzchnia (4) kaniuli (1) i/lub zewnętrzna powierzchnia kaniuli (1) i/lub powierzchnia mandrynu (2) pokryta jest co najmniej jedną warstwą aktywną (6) zawierającą środek biologicznie aktywny. Warstwa aktywna (6) korzystnie ma formę biodegradowalną, umożliwiającą kontrolowane uwalnianie środka biologicznie aktywnego podczas biopsji stercza. Igła do biopsji stercza w odmianie wynalazku charakteryzuje się tym że, w ściance kaniuli uformowany jest wzdłużny kanał przelotowy o zamkniętym profilu przekroju poprzecznego, który przebiega przez całą długość kaniuli lub jej fragment. Kanał przelotowy umożliwia podanie środka biologicznie aktywnego podczas biopsji stercza.
PL411023A 2015-01-22 2015-01-22 Igła do biopsji stercza PL232535B1 (pl)

Priority Applications (9)

Application Number Priority Date Filing Date Title
PL411023A PL232535B1 (pl) 2015-01-22 2015-01-22 Igła do biopsji stercza
CA2989103A CA2989103C (en) 2015-01-22 2016-01-21 Prostate biopsy needle
BR112017015160-0A BR112017015160B1 (pt) 2015-01-22 2016-01-21 Agulha para biópsia de próstata
ES16704946T ES2820377T3 (es) 2015-01-22 2016-01-21 Aguja para biopsia de próstata
EP16704946.9A EP3247282B1 (en) 2015-01-22 2016-01-21 Prostate biopsy needle
PCT/PL2016/000006 WO2016118026A2 (en) 2015-01-22 2016-01-21 Prostate biopsy needle
US15/545,279 US10660622B2 (en) 2015-01-22 2016-01-21 Prostate biopsy needle
JP2017557265A JP6716606B2 (ja) 2015-01-22 2016-01-21 前立腺生検針
AU2016209742A AU2016209742B2 (en) 2015-01-22 2016-01-21 Prostate biopsy needle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL411023A PL232535B1 (pl) 2015-01-22 2015-01-22 Igła do biopsji stercza

Publications (2)

Publication Number Publication Date
PL411023A1 true PL411023A1 (pl) 2016-08-01
PL232535B1 PL232535B1 (pl) 2019-06-28

Family

ID=55361920

Family Applications (1)

Application Number Title Priority Date Filing Date
PL411023A PL232535B1 (pl) 2015-01-22 2015-01-22 Igła do biopsji stercza

Country Status (9)

Country Link
US (1) US10660622B2 (pl)
EP (1) EP3247282B1 (pl)
JP (1) JP6716606B2 (pl)
AU (1) AU2016209742B2 (pl)
BR (1) BR112017015160B1 (pl)
CA (1) CA2989103C (pl)
ES (1) ES2820377T3 (pl)
PL (1) PL232535B1 (pl)
WO (1) WO2016118026A2 (pl)

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598127A (en) * 1968-06-06 1971-08-10 James G Wepsic Catheter having antibacterial substance therein provided with means permitting slow release of said substance
US3699956A (en) * 1970-10-01 1972-10-24 Tecna Corp Percutaneous lead device
FR2421948A1 (fr) 1978-04-06 1979-11-02 Pro Chi Met Produits Chim Meta Procede de preparation d'alliages ferreux sensiblement exempts de cerium, permettant d'ameliorer notamment leurs proprietes mecaniques grace a l'emploi de lanthane, et alliages ferreux obtenus par ce procede
US4838280A (en) 1988-05-26 1989-06-13 Haaga John R Hemostatic sheath for a biopsy needle and method of use
DE3903956A1 (de) 1989-02-10 1990-08-16 Guenter Dr Lohrmann Fuehrungsvorrichtung fuer eine mit einem biopsiestanzgeraet verbundene stanzbiopsienadel
AU7998091A (en) 1990-05-17 1991-12-10 Harbor Medical Devices, Inc. Medical device polymer
US5649547A (en) * 1994-03-24 1997-07-22 Biopsys Medical, Inc. Methods and devices for automated biopsy and collection of soft tissue
US20060052757A1 (en) * 1996-06-04 2006-03-09 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with analgesic or anesthetic
EP0920467A4 (en) * 1996-08-26 1999-10-13 Tyndale Plains Hunter Ltd HYDROPHILES AND HYDROPHOBIC POLYETHERPOLYURETHANES AND THEIR USE
WO2000010622A1 (en) 1998-08-20 2000-03-02 Cook Incorporated Coated implantable medical device
US7175611B2 (en) * 2002-06-05 2007-02-13 Mark Alan Mitchnick Antimicrobial release system
US20030236513A1 (en) 2002-06-19 2003-12-25 Scimed Life Systems, Inc. Implantable or insertable medical devices for controlled delivery of a therapeutic agent
US7674250B2 (en) * 2002-08-05 2010-03-09 Boston Scientific Scimed, Inc. Methods of delivering therapeutic agents
US7597903B2 (en) * 2002-12-02 2009-10-06 Shenkar College Of Engineering And Design Method and composition for producing catheters with antibacterial property
US20070299409A1 (en) 2004-11-09 2007-12-27 Angiotech Biocoatings Corp. Antimicrobial Needle Coating For Extended Infusion
EP2103318A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
EP2103317A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
US20100130850A1 (en) * 2008-11-25 2010-05-27 Pakter Robert L Flexible Core Surgical Device
US8490696B2 (en) 2009-04-20 2013-07-23 David Randolph Smith Method and apparatus to enhance oil recovery in wells
MX2011012580A (es) 2009-05-28 2011-12-14 Angiotech Pharm Inc Juego de agujas de dipositivo de biopsia.
US20120059247A1 (en) * 2010-09-03 2012-03-08 Speeg Trevor W V Echogenic needle for biopsy device
PL214742B1 (pl) 2010-10-11 2013-09-30 Univ Medyczny W Lublinie Sposób otrzymywania przeciwbakteryjnego biomateriału przez immobilizację na jego powierzchni substancji przeciwbakteryjnej
JP5963744B2 (ja) 2011-03-29 2016-08-03 テルモ株式会社 薬剤組成物塗布デバイス
US20130324910A1 (en) 2012-05-31 2013-12-05 Covidien Lp Ablation device with drug delivery component and biopsy tissue-sampling component
MY150885A (en) * 2012-07-16 2014-03-12 Univ Malaya Biopsy track ablation device and method thereof
ES2482612B1 (es) 2012-10-25 2015-05-11 Universitat Pompeu Fabra Sistema para la prevención de infecciones bacterianas en trayectos de aguja

Also Published As

Publication number Publication date
BR112017015160B1 (pt) 2022-08-16
AU2016209742B2 (en) 2021-02-04
BR112017015160A2 (pt) 2018-01-23
ES2820377T3 (es) 2021-04-20
US20180168558A1 (en) 2018-06-21
JP6716606B2 (ja) 2020-07-01
EP3247282B1 (en) 2020-07-15
CA2989103C (en) 2022-01-04
EP3247282A2 (en) 2017-11-29
WO2016118026A3 (en) 2016-09-22
AU2016209742A1 (en) 2017-08-24
US10660622B2 (en) 2020-05-26
WO2016118026A2 (en) 2016-07-28
CA2989103A1 (en) 2016-07-28
JP2018506400A (ja) 2018-03-08
PL232535B1 (pl) 2019-06-28

Similar Documents

Publication Publication Date Title
CL2020002405A1 (es) Inhibidores de kras g12c y métodos para su uso (divisional de la solicitud no. 201903394)
CY1123577T1 (el) Ενωσεις 7-φαινυλοαιθυλαμινο-4η-πυριμιδο[4,5-d][1,3]οξαζιν-2-ονης ως αναστολεις μεταλλαγμενου idh1 και idh2
PH12022551486A1 (en) Compounds and methods for the targeted degradation of androgen receptor
CL2017000507A1 (es) Derivados de benzodiazepina citotóxicos
CO2020010191A2 (es) Inhibidores de cd73
CL2018002291A1 (es) Anticuerpos anti-fgfr2iiib afucosilados (divisional solicitud 201600221)
MX2020003959A (es) Metodos terapeuticos relacionados con los inhibidores de hsp90.
DOP2018000261A (es) Agonista del receptor de glucocorticoides e inmunoconjugados del mismo
JOP20180039A1 (ar) مثبطات pd-1/pd-l1
CL2009000721A1 (es) Combinacion que comprende un anticuerpo aislado anti-igf1r o un fragmento de fijacion de antigeno del mismo en asociacion con leucovorina y 5-fluorouracilo, leucovorina o sunitinib opcionalmente asociado con otro agente quimioterapeutico; y su uso para el tratamiento o prevencion del cancer colorectal.
AR113224A1 (es) Conjugados de anticuerpo que comprenden un agonista de sting
DOP2012000291A (es) 4-yodo-3-nitrobenzamida en combinacion con agentes anti-tumorales para el uso en el tratamiento de cancer de mama
CO6361927A2 (es) Quinazolinas para inhibicion de pdk1
CL2022000339A1 (es) Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2.
CL2012000623A1 (es) Compuestos derivados de 4-[4,4-dimetil-5oxo-3-(piridin-ilmetil)-2-tioxoimidazolidin-1-il]-2-(trifluorometil)benzonitrilo, con propiedades antiandrogenicas; metodo de preparacion; composcion farmaceutica; y su uso para el tratamiento y/o profilaxis de cancer de prostata.
AR094925A1 (es) Aditivos para el control de pérdida de fluido limpio
MX388015B (es) Un anticuerpo anti-csf1r y al menos un agente inmuno-estimulador para usarse en el tratamiento de cáncer.
CL2008002097A1 (es) Compuestos derivados de heterociclos condensados sustituidos, inhibidores de cinasa de fosfatidil-inositol-3; composicion farmaceutica; y uso en el tratamiento del cancer.
CY1119361T1 (el) 3,4-διυδροισοκινολιν-2(1h)-υλικες ενωσεις
MX2021014206A (es) Oligonucleotidos gapmer modificados y metodos de uso.
CL2015003595A1 (es) Inhibidores/antiandrógenos novedosos de cyp17
CU20160055A7 (es) Formulación de fármaco de liberación retardada
UY37800A (es) AGENTES DE iARN PARA LA INHIBICIÓN DE LA EXPRESIÓN DE ALFA-ENaC Y MÉTODOS DE USO
MX2018001608A (es) Composicion densificada para el tratamiento de una formacion subterranea.
EP4004074A4 (en) POLYURETHANE COMPOSITION WITH REDUCED ALDEHYDE EMISSION